Loading…

Impact of a Neuropsychiatric Therapeutics Course and a Case-Based Course on Pharmacy Students’ Mental Health Stigma

Mental health education can reduce the stigma held by medical and nursing students; however, findings in this regard are limited in pharmacy academia. This study investigated the impact of a neuropsychiatric therapeutics course followed by a case-based course on the mental health stigma held by phar...

Full description

Saved in:
Bibliographic Details
Published in:American journal of pharmaceutical education 2023-09, Vol.87 (9), p.100125-100125, Article 100125
Main Authors: Sevak, Rajkumar J., Chandler, Celine, Lui, May C., Kaye, Adam M., Halliwell, Robert F., Rogan, Edward L.
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites cdi_FETCH-LOGICAL-c328t-dc0aa3f49dd2747a9eb2b6f61a5843cbabccf5286acde8f6436eb1d26ddf0ae3
container_end_page 100125
container_issue 9
container_start_page 100125
container_title American journal of pharmaceutical education
container_volume 87
creator Sevak, Rajkumar J.
Chandler, Celine
Lui, May C.
Kaye, Adam M.
Halliwell, Robert F.
Rogan, Edward L.
description Mental health education can reduce the stigma held by medical and nursing students; however, findings in this regard are limited in pharmacy academia. This study investigated the impact of a neuropsychiatric therapeutics course followed by a case-based course on the mental health stigma held by pharmacy students. A survey was conducted of second-year pharmacy students (n = 202) on the first and last day of a neuropsychiatric therapeutics course and 4 months later, at the end of a case-based course. The questionnaires included the Opening Minds Stigma Scale for HealthCare Providers (OMS-HC) scale, Recovery scale, Empowerment scale, and Attribution Questionnaire (AQ-9). Omnibus Friedman tests evaluated the main effect of time, followed by Wilcoxon signed-rank post hoc tests to compare baseline and postcourse scores. Friedman test outcomes showed significant main effects of Time for OMS-HC, Recovery, Empowerment, and AQ-9 scales. Post hoc analysis indicated that compared to the baseline scores, the scores on Recovery and Empowerment scales significantly increased, OMS-HC scores decreased, but AQ-9 scores did not change after the therapeutics course. Compared to the baseline, OMS-HC and AQ-9 scores decreased, Recovery scale score increased, but the Empowerment scale score did not change after the case-based course. The scores did not decrease further after the case-based course compared to those after the therapeutics course. The decreases in OMS-HC and AQ-9 scores and increases in Recovery and Empowerment scores indicate reductions in mental health stigma. Stigma among students was overall reduced after the therapeutics course and this reduction was maintained after the case-based course.
doi_str_mv 10.1016/j.ajpe.2023.100125
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2865783065</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0002945923001262</els_id><sourcerecordid>2865783065</sourcerecordid><originalsourceid>FETCH-LOGICAL-c328t-dc0aa3f49dd2747a9eb2b6f61a5843cbabccf5286acde8f6436eb1d26ddf0ae3</originalsourceid><addsrcrecordid>eNp9kE1OwzAQhS0EEqVwAVZesklxnNhNJTZQAa3En0T31sSeUFf5w3aQuuMaXI-T4KqwZTMzevO9keYRcp6yScpSebmZwKbHCWc8iwJLuTggo1SILJG5nB6SEWOMJ7NczI7JifebiOQi5yMyLJsedKBdRYE-4eC63m_12kJwVtPVGh30OASrPZ13g_NIoTURnYPH5CYW86d3LX1Zg2tAb-lrGAy2wX9_ftHHOEBNFwh1WMeNfWvglBxVUHs8--1jsrq7Xc0XycPz_XJ-_ZDojBchMZoBZFU-M4ZP8ynMsOSlrGQKosgzXUKpdSV4IUEbLCqZZxLL1HBpTMUAszG52J_tXfc-oA-qsV5jXUOL3eBVdIppkTEpIsr3qHad9w4r1TvbgNuqlKldxGqjdhGrXcRqH3E0Xe1NGH_4sOiU1xZbjcY61EGZzv5n_wFL1Yfb</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2865783065</pqid></control><display><type>article</type><title>Impact of a Neuropsychiatric Therapeutics Course and a Case-Based Course on Pharmacy Students’ Mental Health Stigma</title><source>PubMed Central</source><creator>Sevak, Rajkumar J. ; Chandler, Celine ; Lui, May C. ; Kaye, Adam M. ; Halliwell, Robert F. ; Rogan, Edward L.</creator><creatorcontrib>Sevak, Rajkumar J. ; Chandler, Celine ; Lui, May C. ; Kaye, Adam M. ; Halliwell, Robert F. ; Rogan, Edward L.</creatorcontrib><description>Mental health education can reduce the stigma held by medical and nursing students; however, findings in this regard are limited in pharmacy academia. This study investigated the impact of a neuropsychiatric therapeutics course followed by a case-based course on the mental health stigma held by pharmacy students. A survey was conducted of second-year pharmacy students (n = 202) on the first and last day of a neuropsychiatric therapeutics course and 4 months later, at the end of a case-based course. The questionnaires included the Opening Minds Stigma Scale for HealthCare Providers (OMS-HC) scale, Recovery scale, Empowerment scale, and Attribution Questionnaire (AQ-9). Omnibus Friedman tests evaluated the main effect of time, followed by Wilcoxon signed-rank post hoc tests to compare baseline and postcourse scores. Friedman test outcomes showed significant main effects of Time for OMS-HC, Recovery, Empowerment, and AQ-9 scales. Post hoc analysis indicated that compared to the baseline scores, the scores on Recovery and Empowerment scales significantly increased, OMS-HC scores decreased, but AQ-9 scores did not change after the therapeutics course. Compared to the baseline, OMS-HC and AQ-9 scores decreased, Recovery scale score increased, but the Empowerment scale score did not change after the case-based course. The scores did not decrease further after the case-based course compared to those after the therapeutics course. The decreases in OMS-HC and AQ-9 scores and increases in Recovery and Empowerment scores indicate reductions in mental health stigma. Stigma among students was overall reduced after the therapeutics course and this reduction was maintained after the case-based course.</description><identifier>ISSN: 0002-9459</identifier><identifier>EISSN: 1553-6467</identifier><identifier>DOI: 10.1016/j.ajpe.2023.100125</identifier><language>eng</language><publisher>Elsevier Inc</publisher><subject>Case-based course ; Mental health stigma ; Pharmacy students ; Therapeutics course</subject><ispartof>American journal of pharmaceutical education, 2023-09, Vol.87 (9), p.100125-100125, Article 100125</ispartof><rights>2023 American Association of Colleges of Pharmacy</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c328t-dc0aa3f49dd2747a9eb2b6f61a5843cbabccf5286acde8f6436eb1d26ddf0ae3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27923,27924</link.rule.ids></links><search><creatorcontrib>Sevak, Rajkumar J.</creatorcontrib><creatorcontrib>Chandler, Celine</creatorcontrib><creatorcontrib>Lui, May C.</creatorcontrib><creatorcontrib>Kaye, Adam M.</creatorcontrib><creatorcontrib>Halliwell, Robert F.</creatorcontrib><creatorcontrib>Rogan, Edward L.</creatorcontrib><title>Impact of a Neuropsychiatric Therapeutics Course and a Case-Based Course on Pharmacy Students’ Mental Health Stigma</title><title>American journal of pharmaceutical education</title><description>Mental health education can reduce the stigma held by medical and nursing students; however, findings in this regard are limited in pharmacy academia. This study investigated the impact of a neuropsychiatric therapeutics course followed by a case-based course on the mental health stigma held by pharmacy students. A survey was conducted of second-year pharmacy students (n = 202) on the first and last day of a neuropsychiatric therapeutics course and 4 months later, at the end of a case-based course. The questionnaires included the Opening Minds Stigma Scale for HealthCare Providers (OMS-HC) scale, Recovery scale, Empowerment scale, and Attribution Questionnaire (AQ-9). Omnibus Friedman tests evaluated the main effect of time, followed by Wilcoxon signed-rank post hoc tests to compare baseline and postcourse scores. Friedman test outcomes showed significant main effects of Time for OMS-HC, Recovery, Empowerment, and AQ-9 scales. Post hoc analysis indicated that compared to the baseline scores, the scores on Recovery and Empowerment scales significantly increased, OMS-HC scores decreased, but AQ-9 scores did not change after the therapeutics course. Compared to the baseline, OMS-HC and AQ-9 scores decreased, Recovery scale score increased, but the Empowerment scale score did not change after the case-based course. The scores did not decrease further after the case-based course compared to those after the therapeutics course. The decreases in OMS-HC and AQ-9 scores and increases in Recovery and Empowerment scores indicate reductions in mental health stigma. Stigma among students was overall reduced after the therapeutics course and this reduction was maintained after the case-based course.</description><subject>Case-based course</subject><subject>Mental health stigma</subject><subject>Pharmacy students</subject><subject>Therapeutics course</subject><issn>0002-9459</issn><issn>1553-6467</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><recordid>eNp9kE1OwzAQhS0EEqVwAVZesklxnNhNJTZQAa3En0T31sSeUFf5w3aQuuMaXI-T4KqwZTMzevO9keYRcp6yScpSebmZwKbHCWc8iwJLuTggo1SILJG5nB6SEWOMJ7NczI7JifebiOQi5yMyLJsedKBdRYE-4eC63m_12kJwVtPVGh30OASrPZ13g_NIoTURnYPH5CYW86d3LX1Zg2tAb-lrGAy2wX9_ftHHOEBNFwh1WMeNfWvglBxVUHs8--1jsrq7Xc0XycPz_XJ-_ZDojBchMZoBZFU-M4ZP8ynMsOSlrGQKosgzXUKpdSV4IUEbLCqZZxLL1HBpTMUAszG52J_tXfc-oA-qsV5jXUOL3eBVdIppkTEpIsr3qHad9w4r1TvbgNuqlKldxGqjdhGrXcRqH3E0Xe1NGH_4sOiU1xZbjcY61EGZzv5n_wFL1Yfb</recordid><startdate>202309</startdate><enddate>202309</enddate><creator>Sevak, Rajkumar J.</creator><creator>Chandler, Celine</creator><creator>Lui, May C.</creator><creator>Kaye, Adam M.</creator><creator>Halliwell, Robert F.</creator><creator>Rogan, Edward L.</creator><general>Elsevier Inc</general><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>202309</creationdate><title>Impact of a Neuropsychiatric Therapeutics Course and a Case-Based Course on Pharmacy Students’ Mental Health Stigma</title><author>Sevak, Rajkumar J. ; Chandler, Celine ; Lui, May C. ; Kaye, Adam M. ; Halliwell, Robert F. ; Rogan, Edward L.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c328t-dc0aa3f49dd2747a9eb2b6f61a5843cbabccf5286acde8f6436eb1d26ddf0ae3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>Case-based course</topic><topic>Mental health stigma</topic><topic>Pharmacy students</topic><topic>Therapeutics course</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Sevak, Rajkumar J.</creatorcontrib><creatorcontrib>Chandler, Celine</creatorcontrib><creatorcontrib>Lui, May C.</creatorcontrib><creatorcontrib>Kaye, Adam M.</creatorcontrib><creatorcontrib>Halliwell, Robert F.</creatorcontrib><creatorcontrib>Rogan, Edward L.</creatorcontrib><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>American journal of pharmaceutical education</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Sevak, Rajkumar J.</au><au>Chandler, Celine</au><au>Lui, May C.</au><au>Kaye, Adam M.</au><au>Halliwell, Robert F.</au><au>Rogan, Edward L.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Impact of a Neuropsychiatric Therapeutics Course and a Case-Based Course on Pharmacy Students’ Mental Health Stigma</atitle><jtitle>American journal of pharmaceutical education</jtitle><date>2023-09</date><risdate>2023</risdate><volume>87</volume><issue>9</issue><spage>100125</spage><epage>100125</epage><pages>100125-100125</pages><artnum>100125</artnum><issn>0002-9459</issn><eissn>1553-6467</eissn><abstract>Mental health education can reduce the stigma held by medical and nursing students; however, findings in this regard are limited in pharmacy academia. This study investigated the impact of a neuropsychiatric therapeutics course followed by a case-based course on the mental health stigma held by pharmacy students. A survey was conducted of second-year pharmacy students (n = 202) on the first and last day of a neuropsychiatric therapeutics course and 4 months later, at the end of a case-based course. The questionnaires included the Opening Minds Stigma Scale for HealthCare Providers (OMS-HC) scale, Recovery scale, Empowerment scale, and Attribution Questionnaire (AQ-9). Omnibus Friedman tests evaluated the main effect of time, followed by Wilcoxon signed-rank post hoc tests to compare baseline and postcourse scores. Friedman test outcomes showed significant main effects of Time for OMS-HC, Recovery, Empowerment, and AQ-9 scales. Post hoc analysis indicated that compared to the baseline scores, the scores on Recovery and Empowerment scales significantly increased, OMS-HC scores decreased, but AQ-9 scores did not change after the therapeutics course. Compared to the baseline, OMS-HC and AQ-9 scores decreased, Recovery scale score increased, but the Empowerment scale score did not change after the case-based course. The scores did not decrease further after the case-based course compared to those after the therapeutics course. The decreases in OMS-HC and AQ-9 scores and increases in Recovery and Empowerment scores indicate reductions in mental health stigma. Stigma among students was overall reduced after the therapeutics course and this reduction was maintained after the case-based course.</abstract><pub>Elsevier Inc</pub><doi>10.1016/j.ajpe.2023.100125</doi><tpages>1</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0002-9459
ispartof American journal of pharmaceutical education, 2023-09, Vol.87 (9), p.100125-100125, Article 100125
issn 0002-9459
1553-6467
language eng
recordid cdi_proquest_miscellaneous_2865783065
source PubMed Central
subjects Case-based course
Mental health stigma
Pharmacy students
Therapeutics course
title Impact of a Neuropsychiatric Therapeutics Course and a Case-Based Course on Pharmacy Students’ Mental Health Stigma
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-11T09%3A43%3A14IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Impact%20of%20a%20Neuropsychiatric%20Therapeutics%20Course%20and%20a%20Case-Based%20Course%20on%20Pharmacy%20Students%E2%80%99%20Mental%20Health%20Stigma&rft.jtitle=American%20journal%20of%20pharmaceutical%20education&rft.au=Sevak,%20Rajkumar%20J.&rft.date=2023-09&rft.volume=87&rft.issue=9&rft.spage=100125&rft.epage=100125&rft.pages=100125-100125&rft.artnum=100125&rft.issn=0002-9459&rft.eissn=1553-6467&rft_id=info:doi/10.1016/j.ajpe.2023.100125&rft_dat=%3Cproquest_cross%3E2865783065%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c328t-dc0aa3f49dd2747a9eb2b6f61a5843cbabccf5286acde8f6436eb1d26ddf0ae3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2865783065&rft_id=info:pmid/&rfr_iscdi=true